Literature DB >> 26984830

Naegleria fowleri That Induces Primary Amoebic Meningoencephalitis: Rapid Diagnosis and Rare Case of Survival in a 12-Year-Old Caucasian Girl.

Andrew L Dunn1, Tameika Reed2, Charlotte Stewart2, Rebecca A Levy3.   

Abstract

Primary amoebic meningoencephalitis (PAM) is a rare and almost always fatal disease that is caused by Naegleria fowleri, a freshwater thermophilic amoeba. Our case involves an adolescent female who presented with fever of unknown origin. A lumbar puncture was performed, and the Wright-Giemsa and Gram stained cerebrospinal fluid (CSF) cytospin slides showed numerous organisms. Experienced medical technologists in the microbiology and hematology laboratories identified the organisms as morphologically consistent with Naegleria species. The laboratory made a rapid diagnosis and alerted emergency department care providers within 75 minutes. The patient was treated for PAM with amphotericin, rifampin, azithromycin, fluconazole and aggressive supportive therapy including dexamethasone. The Centers for Disease Control and Prevention (CDC) was contacted, and miltefosine, an investigational medication, was started. Additional treatment included an intraventricular shunt and controlled hypothermia in order to mitigate potential cerebral edema. Our patient is a rare success story, as she was diagnosed swiftly, successfully treated, and survived PAM. © American Society for Clinical Pathology, 2016. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Naegleria fowleri; primary amoebic meningocephalitis; thermophilic amoeba, microbiology, body fluid morphology, and body fluid interpretation

Mesh:

Substances:

Year:  2016        PMID: 26984830     DOI: 10.1093/labmed/lmw008

Source DB:  PubMed          Journal:  Lab Med        ISSN: 0007-5027


  5 in total

1.  Successful Treatment of Primary Amoebic Meningoencephalitis Using a Novel Therapeutic Regimen Including Miltefosine and Voriconazole.

Authors:  Dalila Y Martínez; Fanny Bravo-Cossio; María Del Carmen Valdivia-Tapia; Nilton Yhuri Carreazo; Alfonso M Cabello-Vilchez
Journal:  Acta Parasitol       Date:  2022-07-21       Impact factor: 1.534

2.  Opportunistic free-living amoebal pathogens.

Authors:  Mohammad Ridwane Mungroo; Naveed Ahmed Khan; Sutherland Maciver; Ruqaiyyah Siddiqui
Journal:  Pathog Glob Health       Date:  2021-10-02       Impact factor: 3.735

3.  A Fatal Case of Primary Amoebic Meningoencephalitis from Recreational Waters.

Authors:  Edward Hamaty; Saif Faiek; Minesh Nandi; David Stidd; Manish Trivedi; Hari Kandukuri
Journal:  Case Rep Crit Care       Date:  2020-05-28

Review 4.  Drugs used for the treatment of cerebral and disseminated infections caused by free-living amoebae.

Authors:  Alexandre Taravaud; Zineb Fechtali-Moute; Philippe M Loiseau; Sébastien Pomel
Journal:  Clin Transl Sci       Date:  2021-03-01       Impact factor: 4.689

5.  A case report: primary amoebic meningoencephalitis in a young Zambian adult.

Authors:  Mashina Chomba; Luchenga A Mucheleng'anga; Sombo Fwoloshi; Joseph Ngulube; Mable M Mutengo
Journal:  BMC Infect Dis       Date:  2017-08-01       Impact factor: 3.090

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.